ReviewAnnals of surgical oncology2026

The Landmark Series: Neoadjuvant Therapy for Patients with Resectable Gastroesophageal Junction Adenocarcinomas.

Morgan F Pettigrew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.